MedTrace Logo

Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy

NCT05622617 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-11-18

No results posted yet for this study

Summary

This study aims to investigate the correlation between paclitaxel-induced neuropathy and the measurement values of serum IL-20 levels at baseline and during chemotherapy in patients who will receive neoadjuvant or adjuvant paclitaxel chemotherapy with the diagnosis of early-stage or locally advanced breast cancer

Conditions

  • Neuropathy Associated With Dysproteinaemias

Interventions

DRUG

no intervention

no intervention

Sponsors & Collaborators

  • Namik Kemal University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-03-01
Completion
2023-04-01
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622617 on ClinicalTrials.gov